Economic evaluation of typhoid vaccination in a prolonged typhoid outbreak setting: The case of Kasese district in Uganda

Vaccine

Volumn 33, Issue 17, 2015, Pages 2079-2085

  Carias, Cristina ^a,b   Walters, Maroya Spalding ^a,c   Wefula, Edward ^d   Date, Kashmira A ^a   Swerdlow, David L ^a   Vijayaraghavan, Maya ^a   Mintz, Eric ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Ihrc Inc   (United States)

^c NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^d Kilembe Mines Hospital   (Uganda)

Author keywords

Cost effectiveness; Typhoid; Typhoid vaccination; Uganda

Indexed keywords

TYPHOID VACCINE; TYPHOID PARATYPHOID VACCINE;

ARTICLE; DISABILITY ADJUSTED LIFE YEAR; ECONOMIC EVALUATION; EPIDEMIC; HEALTH CARE COST; HUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; RURAL AREA; TYPHOID FEVER; UGANDA; VACCINATION; ADOLESCENT; CHILD; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; MALE; PRACTICE GUIDELINE; PRESCHOOL CHILD; QUALITY ADJUSTED LIFE YEAR; RURAL POPULATION; STATISTICS AND NUMERICAL DATA; TIME; WORLD HEALTH ORGANIZATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; DISEASE OUTBREAKS; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; QUALITY-ADJUSTED LIFE YEARS; RURAL POPULATION; TIME FACTORS; TYPHOID FEVER; TYPHOID-PARATYPHOID VACCINES; UGANDA; VACCINATION; WORLD HEALTH ORGANIZATION;

EID: 84925969577     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.02.027     Document Type: Article

References (32)

1. Buckle G.C. Walker C.L. Black R.E. Typhoid fever and paratyphoid fever: systematic review to estimate global morbidity and mortality for 2010. J Glob Health 2012, 2(1):10401.
2. Crump J.A. Luby S.P. Mintz E.D. The global burden of typhoid fever. Bull World Health Organ 2004, 82(5):346-353.
3. Breiman R.F. Cosmas L. Njuguna H. Audi A. Olack B. Ochieng J.B. et al. Population-based incidence of typhoid fever in an urban informal settlement and a rural area in Kenya: implications for typhoid vaccine use in Africa. PLoS ONE 2012, 7(1):e29119.
4. Lutterloh E. Likaka A. Sejvar J. Manda R. Naiene J. Monroe S.S. et al. Multidrug-resistant typhoid fever with neurologic findings on the Malawi-Mozambique border. Clin Infect Dis 2012, 54(8):1100-1106.
5. Neil K.P. Sodha S.V. Lukwago L. O-Tipo S. Mikoleit M. Simington S.D. et al. A large outbreak of typhoid fever associated with a high rate of intestinal perforation in Kasese District, Uganda, 2008-2009. Clin Infect Dis 2012, 54(8):1091-1099.
6. Slayton R.B. Date K.A. Mintz E.D. Vaccination for typhoid fever in Sub-Saharan Africa. Hum Vaccines Immunother 2013, 9(4).
7. Imanishi M. Kweza P.F. Slayton R.B. Urayai T. Ziro O. Mushayi W. et al. Household water treatment uptake during a public health response to a large typhoid fever outbreak in Harare, Zimbabwe. Am J Trop Med Hyg 2014, 90(5):945-954.
8. Bhutta Z. Chaignat C. Clemens J. Favorov M. Ivanoff B. Klugman K. et al. Background paper on vaccination against typhoid fever using new-generation vaccines 2007, WHO SAGE, Available from: http://www.who.int/immunization/sage/SAGE_Background_paper_typhoid_newVaccines.pdf.
9. Sur D. Ochiai R.L. Bhattacharya S.K. Ganguly N.K. Ali M. Manna B. et al. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India. N Engl J Med 2009, 361(4):335-344.
10. Thiem V.D. Danovaro-Holliday M. Canh D.G. Son N.D. Hoa N.T. Thuy D.T.D. et al. The feasibility of a school-based VI polysaccharide vaccine mass immunization campaign in Hue City, central Vietnam: streamlining a typhoid fever preventive strategy. Southeast Asian J Trop Med Public Health 2006, 37(3):515-522.
11. Dewan D.K. Community based typhoid vaccination program in New Delhi, India. 8th international conference: typhoid fever and other invasive salmonelloses 2013.
12. Yang H. Wu C. Xie G. Gu Q. Wang B. Wang L. et al. Efficacy trial of Vi polysaccharide vaccine against typhoid fever in south-western China. Bull World Health Organ 2001, 79(7):625-631.
13. Scobie H.M. Nilles E. Kama M. Kool J.L. Mintz E. Wannemuehler K.A. et al. Impact of a targeted typhoid vaccination campaign following cyclone Tomas, Republic of Fiji, 2010. Am J Trop Med Hyg 2014, 90(6):1031-1038.
14. Cook J. Jeuland M. Whittington D. Poulos C. Clemens J. Sur D. et al. The cost-effectiveness of typhoid Vi vaccination programs: calculations for four urban sites in four Asian countries. Vaccine 2008, 26(50):6305-6316.
15. Muyembe-Tamfum J. Veyi J. Kaswa M. Lunguya O. Verhaegen J. Boelaert M. An outbreak of peritonitis caused by multidrug-resistant Salmonella Typhi in Kinshasa, Democratic Republic of Congo. Travel Med Infect Dis 2009, 7(1):40-43.
16. Walters M.S. Routh J. Mikoleit M. Kadivane S. Ouma C. Mubiru D. et al. Shifts in geographic distribution and antimicrobial resistance during a prolonged typhoid fever outbreak - Bundibugyo and Kasese Districts, Uganda, 2009-2011. PLoS Negl Trop Dis 2014, 8(3):e2726.
17. WHO guide for standardization of economic evaluations of immunization programmes 2008, World Health Organization, Department of Immunization, Vaccines and Biologicals.
18. National burden of disease manual: a practical guide 2001, World Health Organization, Global Program on Evidence for Health Policy.
19. International Data Base Population pyramid for Uganda 2012, Available from: http://www.census.gov/population/international/ [accessed January 2015].
20. Mogasale V. Maskery B. Ochiai R.L. Lee J.S. Mogasale V.V. Ramani E. et al. Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment. Lancet Glob Health 2014, 2(10):e570-e580.
21. Mogasale V. Desai S.N. Mogasale V.V. Park J.K. Ochiai R.L. Wierzba T.F. Case fatality rate and length of hospital stay among patients with typhoid intestinal perforation in developing countries: a systematic literature review. PLOS ONE 2014, 9(4):e93784.
22. Anwar E. Goldberg E. Fraser A. Acosta C.J. Paul M. Leibovici L. Vaccines for preventing typhoid fever. Cochrane Database Syst Rev 2014, 1:CD001261.
23. Consumer Price Index Uganda Bureau of Statistics, 2014.
24. Treasury reporting rates of exchange as of September 30, 2014 2014, Bureau of the Fiscal Service, U.S. Department of the Treasury.
25. Kumaranayake L. The real and the nominal? Making inflationary adjustments to cost and other economic data. Health Policy Plan 2000, 15(2):230-234.
26. Immunization service delivery - projected vaccine wastage 2014, Available from: http://apps.who.int/immunization_delivery/systems_policy/logistics_projected_wastage/en/index.html [accessed January 2014].
27. Parmar D. Baruwa E.M. Zuber P. Kone S. Impact of wastage on single and multi-dose vaccine vials: implications for introducing pneumococcal vaccines in developing countries. Hum Vaccines 2010, 6(3):270-278.
28. GDP per capita: Uganda 2015, Available from: http://data.un.org/CountryProfile.aspx?crName=Uganda [accessed January 2015].
29. Pitzer V.E. Bowles C.C. Baker S. Kang G. Balaji V. Farrar J.J. et al. Predicting the impact of vaccination on the transmission dynamics of typhoid in South Asia: a mathematical modeling study. PLoS Negl Trop Dis 2014, 8(1):e2642.
30. Nakao J.H. A knowledge, attitudes, and practices survey to inform a typhoid fever intervention campaign - Kasese District, Rural Western Uganda. Epidemic intelligence service conference 2013.
31. Jeuland M. Cook J. Poulos C. Clemens J. Whittington D. Cost-effectiveness of new-generation oral cholera vaccines: a multisite analysis. Value Health 2009, 12(6):899-908.
32. Global health observatory: Uganda - country data and statistics 2015, Available from: http://www.who.int/gho/countries/uga/en/ [accessed January 2015].